Follow
Fabian Sesterhenn
Fabian Sesterhenn
Novartis Biomedical Research- previously ETH and EPFL
No verified email
Title
Cited by
Cited by
Year
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
JG Jardine, DW Kulp, C Havenar-Daughton, A Sarkar, B Briney, D Sok, ...
Science 351 (6280), 1458-1463, 2016
4252016
Tailored immunogens direct affinity maturation toward HIV neutralizing antibodies
B Briney, D Sok, JG Jardine, DW Kulp, P Skog, S Menis, R Jacak, ...
Cell 166 (6), 1459-1470. e11, 2016
2542016
De novo protein design enables the precise induction of RSV-neutralizing antibodies
F Sesterhenn, C Yang, J Bonet, JT Cramer, X Wen, Y Wang, CI Chiang, ...
Science 368 (6492), eaay5051, 2020
1532020
Minimally mutated HIV-1 broadly neutralizing antibodies to guide reductionist vaccine design
JG Jardine, D Sok, JP Julien, B Briney, A Sarkar, CH Liang, EA Scherer, ...
PLoS pathogens 12 (8), e1005815, 2016
1292016
Bottom-up de novo design of functional proteins with complex structural features
C Yang, F Sesterhenn, J Bonet, EA van Aalen, L Scheller, LA Abriata, ...
Nature Chemical Biology, 1-9, 0
84
Rosetta FunFolDes–A general framework for the computational design of functional proteins
J Bonet, S Wehrle, K Schriever, C Yang, A Billet, F Sesterhenn, A Scheck, ...
PLoS computational biology 14 (11), e1006623, 2018
382018
Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen
F Sesterhenn, M Galloux, SS Vollers, L Csepregi, C Yang, D Descamps, ...
PLoS biology 17 (2), e3000164, 2019
352019
Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications
L Malinovska, V Cappelletti, D Kohler, I Piazza, TH Tsai, M Pepelnjak, ...
Nature Protocols 18 (3), 659-682, 2023
292023
Structure-based immunogen design—leading the way to the new age of precision vaccines
F Sesterhenn, J Bonet, BE Correia
Current opinion in structural biology 51, 163-169, 2018
232018
Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker
MT Mackmull, L Nagel, F Sesterhenn, J Muntel, J Grossbach, P Stalder, ...
Nature structural & molecular biology 29 (10), 978-989, 2022
182022
rstoolbox-a Python library for large-scale analysis of computational protein design data and structural bioinformatics
J Bonet, Z Harteveld, F Sesterhenn, A Scheck, BE Correia
BMC bioinformatics 20, 1-13, 2019
132019
A generic framework for hierarchical de novo protein design
Z Harteveld, J Bonet, S Rosset, C Yang, F Sesterhenn, BE Correia
Proceedings of the National Academy of Sciences 119 (43), e2206111119, 2022
102022
The physiological landscape and specificity of antibody repertoires
L Csepregi, KB Hoehn, D Neumeier, JM Taft, S Friedensohn, CR Weber, ...
bioRxiv, 2021.09. 15.460420, 2021
52021
Systematic identification of structure-specific protein–protein interactions
A Holfeld, D Schuster, F Sesterhenn, P Stalder, W Haenseler, ...
bioRxiv, 2023.02. 01.522707, 2023
32023
Protein destabilization underlies pathogenic missense mutations in ARID1B
F Mermet-Meillon, S Mercan, B Bauer-Probst, C Allard, M Bleu, K Calkins, ...
Nature Structural & Molecular Biology, 1-5, 2024
22024
mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1B
GS Cremosnik, Y Mesrouze, P Zueger, D Furkert, F Grandjean, D Argoti, ...
ACS Chemical Biology, 2024
2024
Author Correction: Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications
L Malinovska, V Cappelletti, D Kohler, I Piazza, TH Tsai, M Pepelnjak, ...
Nature Protocols 18 (6), 1979-1979, 2023
2023
Immunogen
B Correia, F Sesterhenn, C Yang, J Bonet
US Patent App. 17/622,468, 2022
2022
Immunogen
B Correia, F Sesterhenn, C Yang, J Bonet
2020
Expanding beyond the natural protein repertoire to engineer targeted vaccines and diagnostics
F Sesterhenn
EPFL, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20